Pharmaceutical Outsourcing covers news of importance to the contract services segment of the pharmaceutical industry.
Collected from the most trusted on-line resources, these news stories are chosen and published here based on their relevance to the pharmaceutical industry.
Topics of interest typically include: mergers and acquisitions, service additions, new capabilities, personnel changes, news from the FDA and other international regulatory and standard-setting agencies, and new outsourcing contracts and deals.
If you are looking to stay up-to-date with the news in your industry, this resource is vital for your industry knowledge.
CellCarta and Olink Proteomics AB announced a strategic collaboration to offer Olink® Target 96 & Target 48 to pharmaceutical and biotech customers, advancing targeted protein biomarker quantification in clinical studies.
read more
CellCarta announced the appointment of Ehab A. El-Gabry, MD, as Chief Medical Officer and Head of Companion Diagnostics. In this role, Dr. El-Gabry will provide medical and scientific leadership across CellCarta's biomarker programs and lead the ...
read more
CellCarta and Pillar Biosciences announced a global multi-year strategic partnership to broaden access to fast, operationally streamlined next-generation sequencing (NGS) tumor profiling for biopharma sponsors and clinical research partners worldwide...
read more
CellCarta, a global provider of precision medicine services, has announced the acquisition of Reveal Biosciences.
read more
Tuesday, December 14, 2021
CellCarta, a global provider of precision medicine laboratory services, announced the acquisition of Biogazelle ("Biogazelle"), a leader in genomic testing solutions. Located in Ghent (Belgium), Biogazelle develops and deploys high-end digital PCR (...
read more
Cellbox Solutions is pleased to announce the opening of its new headquarters in Norderstedt, which is located nearby Hamburg, Germany.
read more
Cellaria announced a new sales and marketing agreement with Biological Industries to promote custom stem cell services.
read more
Cellaria, LLC has announced the expansion of its offerings to include a suite of stem cell services. The initiative advances Cellaria’s mission to provide more accurate patient and disease-specific cell models to help researchers focus and accelerate...
read more
Cellares, an first Integrated Development and Manufacturing Organization (IDMO) dedicated to clinical and industrial-scale cell therapy manufacturing, announced that Bristol Myers Squibb has joined its Technology Adoption Partnership (TAP) program.
read more
Cell Medica announced the acquisition of Catapult Therapy TCR, a subsidiary of Cell and Gene Therapy Catapult, and the initiation of a collaboration to establish cell therapy manufacturing for Cell Medica at CGT Catapult’s GMP manufacturing facility ...
read more
Wednesday, November 11, 2020
Cell Guidance Systems announced the launch of a new product for the purification of exosomes from blood and other samples.
read more
Thursday, November 10, 2016
Cell Culture Company (C3), a biopharmaceutical developer and manufacturer, has entered into an agreement with a China-based joint venture to produce a clinical-grade antibody-based therapeutic vaccine targeting pancreatic cancer.
read more
uBriGene, a cell & gene therapy contract development and manufacturing organization (CDMO), is expanding into the US market with the acquisition of a state-of-the-art GMP manufacturing facility from NASDAQ-listed company Mustang Bio, Inc.
read more
The Cell and Gene Therapy Catapult (CGT Catapult) announced it has licensed data from its pluripotent stem cell development program ‘Cell Plasticity’ to Japanese food and amino acid company Ajinomoto.
read more
Wednesday, August 23, 2023
The Cell and Gene Therapy Catapult (CGT Catapult), an independent innovation and technology organization specializing in the advancement of cell and gene therapies, announces a collaboration with Rentschler Biopharma, a leading global contract ...
read more